PRE-ECLAMPSIA
PLACENTAL PROTEIN 13
ELISA ASSAY

PLACENTAL PROTEIN 13 ELISA KIT

Cat Num. ConditioningPackage size  
12-KI-EK0901kit40
ELISA test used for determination of PP13 protein in human serum for early detection of high risk pregnancy
The Placental Protein 13 ELISA Kit (PP13 Kit) is a quantitative, in vitro diagnostic test for the determination of Placental Protein 13 (PP13) in human body fluids, particularly but not limited to pregnant women serum, using an Enzyme-Linked Immuno-Sorbent Assay (ELISA). The PP13 level can be determined by the PP13 Kits already during the first trimester. The level of PP13 determined during this period (gestational week 10-13) can be used to screen for the pregnant woman risk to develop preeclampsia 15-20 weeks later, during the mid-second or the third trimester of pregnancy.

Kit contents:

  • 12 ELISA test strips (12 x 8 wells)
  • 1 bottle of Wash solution, concentrate (60 mL)
  • 1 bottle of Sample Dilution buffer (18 mL)
  • 1 vial of Reference material (2.4 ng of PP13)
  • 1 vial of plasma pool from pregnant women
  • 1 vial of plasma pool from non pregnant women
  • 1 vial of Dithiothreitol (DTT)
  • 1 bottle of Buffer A (60 mL)
  • 1 vial of biotinylated antibody
  • 1 vial of Peroxydase coupled Streptavidin
  • 1 bottle of TMB (12 mL)
  • 1 bottle of Stop solution (15 mL)
Information
Preeclampsia is a disorder of pregnancy characterized by high blood pressure and large amounts of protein in the urine. Though present in the majority of cases, protein in the urine need not be present to make the diagnosis of preeclampsia. It involves many body systems and evidence of associated organ dysfunction may be used to make the diagnosis when hypertension is present. This includes the presence of a low blood platelet count (thrombocytopenia), impaired liver function, the development of new kidney dysfunction, fluid accumulation in the lungs (pulmonary edema), and/or new-onset brain or visual disturbances. If left untreated, preeclampsia can develop into eclampsia, the life-threatening occurrence of seizures during pregnancy. Preeclampsia is associated with multiple maternal and fetal adverse effects.
Features & benefits
  • Allows an early detection of preeclampsia (weeks 8-14)
  • Precise, Consistent, Reliable
  • Easy to use and automatable ELISA assay
  • Test performed on serum samples
  • Partner team in EC Health FP7 ASPRE Project

THEY TRUST US

OUR PARTNERS